Onchocerciasis Control: Vision for the Future from a Ghanian perspective

[1]  A. Hoerauf.  Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis , 2008, Current opinion in infectious diseases.

[2]  A. Hoerauf,et al.  Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus , 2008, Parasitology Research.

[3]  M. Boussinesq,et al.  Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.

[4]  R. Fimmers,et al.  Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study , 2007, Medical Microbiology and Immunology.

[5]  R. Prichard,et al.  Ivermectin resistance and overview of the Consortium for Anthelmintic Resistance SNPs , 2007, Expert opinion on drug discovery.

[6]  M. Reich,et al.  The Future of Onchocerciasis Control in Africa , 2007, PLoS neglected tropical diseases.

[7]  M. Boussinesq,et al.  Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment , 2007, PLoS neglected tropical diseases.

[8]  D. Boakye,et al.  Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study , 2007, The Lancet.

[9]  K. Johnston,et al.  Wolbachia in filarial parasites: Targets for filarial infection and disease control , 2007, Current infectious disease reports.

[10]  B. Boatin,et al.  The future of onchocerciasis control in Africa , 2006, The Lancet.

[11]  Mark J. Taylor,et al.  Onchocerca parasites and Wolbachia endosymbionts: evaluation of a spectrum of antibiotic types for activity against Onchocerca gutturosa in vitro , 2006, Filaria journal.

[12]  D. Boakye,et al.  Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana , 2004, Annals of tropical medicine and parasitology.

[13]  D. Boakye,et al.  An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana , 2004, Annals of tropical medicine and parasitology.

[14]  Report of a Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas , 2003, Filaria journal.

[15]  B. Duke.  Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas. , 2003, Filaria journal.

[16]  A. Hoerauf,et al.  Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. , 2003, Microbes and infection.

[17]  M. Neira,et al.  Final report of the Conference on the eradicability of Onchocerciasis , 2003, Filaria journal.

[18]  C. Mackenzie,et al.  Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis. , 2002, Acta tropica.

[19]  M. Boussinesq,et al.  Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial , 2002, The Lancet.

[20]  T. Nutman,et al.  Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. , 2002, The Journal of infectious diseases.

[21]  A. Hoerauf,et al.  The Role of Endosymbiotic Wolbachia Bacteria in the Pathogenesis of River Blindness , 2002, Science.

[22]  G. von Samson-Himmelstjerna,et al.  Filaricidal efficacy of anthelmintically active cyclodepsipeptides. , 2001, International journal for parasitology.

[23]  G. von Samson-Himmelstjerna,et al.  Effects of Bay 44-4400, a new cyclodepsipeptide, on developing stages of filariae (Acanthocheilonema viteae, Brugia malayi, Litomosoides sigmodontis) in the rodent Mastomys coucha. , 2001, Acta tropica.

[24]  A. Hoerauf,et al.  Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment , 2001, The Lancet.

[25]  A. Hoerauf,et al.  Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis , 2000, The Lancet.

[26]  J. Habbema,et al.  Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. , 1995, The Journal of infectious diseases.

[27]  S. Kläger,et al.  How long do the effects of ivermectin on adult Onchocerca volvulus persist? , 1993, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[28]  R. Post,et al.  The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone. , 1992, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[29]  R. Prichard,et al.  The problem of anthelmintic resistance in nematodes. , 1980, Australian veterinary journal.

[30]  R. Fimmers,et al.  Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus , 2008, Parasitology Research.

[31]  Boakye A Boatin,et al.  Control of onchocerciasis. , 2006, Advances in parasitology.

[32]  A. Hoerauf,et al.  Wolbachia bacterial endosymbionts of filarial nematodes. , 2005, Advances in parasitology.